Monographie - Isavuconazonium sulfate

Последнее обновление :
08/05/2024

Isavuconazonium sulfate

Химическая структура

Товарное название

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cresemba

Великобритания, Германия, Испания, Перу, Соединённые Штаты Америки, Франция, чили

Библиография : Isavuconazonium sulfate

	тип	публикация
2864	Лаборатория	Isavuconazonium (Cresemba®) - Summary of Product Characteristics Astellas Pharma 2015
3578	Лаборатория	Cisplatin - Summary of Product Characteristics Accord Healthcare 2011
3644	Лаборатория	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3827	плакат	Ghazi I.M, Hamada Y, Nicolau D.P. Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015
3828	плакат	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	плакат	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	Журнал	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145	Журнал	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4801	Журнал	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales